IGF1R and breast carcinoma: Others have shown that this phenolic compound can mimic the effects of anti-oestrogens by altering key growth regulatory signals involving ER/cyclin D1 and IGF1R/p-AKT, thereby reducing the proliferation of breast cancer cells [26].